ExpreS2ion Biotech Holding AB (publ) (STO:EXPRS2)
Sweden · Delayed Price · Currency is SEK 4.985
-0.045 (-0.89%)
Mar 19, 2026, 12:40 PM CET
STO:EXPRS2 Revenue
ExpreS2ion Biotech Holding AB had revenue of 3.53M SEK in the quarter ending December 31, 2025, with 62.21% growth. This brings the company's revenue in the last twelve months to 10.85M, up 36.83% year-over-year. In the year 2024, ExpreS2ion Biotech Holding AB had annual revenue of 7.83M, down -11.07%.
Revenue (ttm)
10.85M
Revenue Growth
+36.83%
P/S Ratio
1.64
Revenue / Employee
542.60K
Employees
20
Market Cap
17.76M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.83M | -974.00K | -11.07% |
| Dec 31, 2023 | 8.80M | 2.65M | 43.07% |
| Dec 31, 2022 | 6.15M | -7.58M | -55.21% |
| Dec 31, 2021 | 13.73M | -1.53M | -10.04% |
| Dec 31, 2020 | 15.26M | 1.43M | 10.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nanologica AB | 21.13M |
| Fluicell AB | 15.22M |
| AcouSort AB | 10.43M |
| Aptahem AB | 2.59M |
| 2cureX AB | 1.98M |
| Pila Pharma AB | 1.13M |
| NanoEcho AB | 487.00K |
| Stayble Therapeutics AB | 47.00K |